Results 1 to 10 of about 1,549,135 (226)

TB and HIV Therapeutics: Pharmacology Research Priorities. [PDF]

open access: yesAIDS Res Treat, 2012
An unprecedented number of investigational drugs are in the development pipeline for the treatment of tuberculosis. Among patients with tuberculosis, co-infection with HIV is common, and concurrent treatment of tuberculosis and HIV is now the standard ...
Dooley KE   +3 more
europepmc   +3 more sources

Medical Pharmacology and Therapeutics by Derek G. Waller and Anthony P. Sampson [PDF]

open access: yesBritish Journal of Pharmacy, 2017
A thorough and contemporaneous working knowledge of both pharmacology and therapeutics is integral to the current practice of pharmacy, and both disciplines form a significant and rudimentary part of the undergraduate curricula.
Amie Bain
doaj   +2 more sources

Emerging principles of cytokine pharmacology and therapeutics

open access: yesNature Reviews Drug Discovery, 2022
Robert Saxton   +2 more
exaly   +2 more sources

Educating Medical Students on How to Prescribe Anti-Hyperglycaemic Drugs: A Practical Guide

open access: yesDiabetology, 2023
In the light of the rapidly increasing global incidence of, and therapeutic arsenal for, diabetes type 2, this brief report underscores the need for advancements in clinical pharmacology and therapeutics (CPT) education with regard to diabetes type 2. We
Erik M. Donker   +5 more
doaj   +1 more source

Clinical Pharmacology of RNA Interference–Based Therapeutics: A Summary Based on Food and Drug Administration–Approved Small Interfering RNAs

open access: yesDrug Metabolism And Disposition, 2022
RNA-based oligonucleotide therapeutics are revolutionizing drug development for disease treatment. This class of therapeutics differs from small molecules and protein therapeutics in various ways, including both its mechanism of action and clinical ...
Xing Jing   +3 more
semanticscholar   +1 more source

Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology.

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022
BACKGROUND Lung diseases including chronic obstructive pulmonary disease (COPD), infections like influenza, acute respiratory distress syndrome (ARDS), asthma and pneumonia lung cancer (LC) are common causes of sickness and death worldwide due to their ...
M. Rahman   +20 more
semanticscholar   +1 more source

Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study

open access: yesJournal of Diabetes Research, 2022
Aims. This study is aimed at clarifying the relationship between visit-to-visit variability of glycated hemoglobin (HbA1c) and the risk of diabetic kidney disease (DKD) and to identifying the most useful index of visit-to-visit variability of HbA1c ...
Yunyi Yan   +15 more
doaj   +1 more source

Phytochemical Analysis, Acute Toxicity, as well as Antihyperglycemic and Antidiabetic Activities of Corchorus olitorius L. Leaf Extracts

open access: yesThe Scientific World Journal, 2022
Backgroundand Aim. Diabetes mellitus is a metabolic disorder that has no known cure with continuous endeavors to find a therapy for the condition. According to some studies, traditional leafy vegetables could prevent and manage diabetes by modifying the ...
Rebecca Nakaziba   +3 more
doaj   +1 more source

Utilization of Physiologically Based Pharmacokinetic Modeling in Clinical Pharmacology and Therapeutics: an Overview

open access: yesCurrent Pharmacology Reports, 2020
The purpose of this review was to assess the advancement of applications for physiologically based pharmacokinetic (PBPK) modeling in various therapeutic areas.
Courtney L Perry   +3 more
semanticscholar   +1 more source

Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID‐19

open access: yesClinical and Translational Science, 2020
The global response to finding therapeutics for coronavirus disease 2019 (COVID‐19) is chaotic even if well intentioned. There is an opportunity, but more importantly, an obligation for the global clinical and quantitative pharmacology community to come ...
Dan Hartman   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy